CLVS - Clovis Oncology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $8.61. This is a potential upside of $8.61 (0%) from yesterday's end of day stock price of $0.

Clovis Oncology's activity chart (see below) currently has 161 price targets and 106 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.61% with an average time for these price targets to be met of 101.84 days.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 14-Jun-2022. First documented stock forecast 13-Apr-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$4

3 years 5 months 29 days ago
(14-Jun-2022)

0/11 (0%)

$2.53 (172.11%)

Hold

$4.75

$4.66 (5177.78%)

$5.75

4 years 1 months 10 days ago
(03-Nov-2021)

10/12 (83.33%)

$0.06 (1.28%)

65

Sell

5 years 1 months 7 days ago
(06-Nov-2020)

3/5 (60%)

$5.73 (134.19%)

42

Buy

$16

$15.91 (17677.78%)

$17

5 years 4 months 6 days ago
(07-Aug-2020)

5/12 (41.67%)

$10.58 (195.20%)

77

Sell

$4

$3.91 (4344.44%)

$3

5 years 7 months 7 days ago
(06-May-2020)

3/5 (60%)

$-4.07 (-50.43%)

191

Show more analysts

Please expand the browser size to see the chart

What is CLVS (Clovis Oncology) average time for price targets to be met?

On average it took 101.84 days on average for the stock forecasts to be realized with a an average price target met ratio 54.61

Which analyst has the current highest performing score on CLVS (Clovis Oncology) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on CLVS (Clovis Oncology)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on CLVS

Which analyst is the currently most bullish on CLVS (Clovis Oncology)?

Thomas Shrader with highest potential upside - $124.91

Which analyst is the currently most reserved on CLVS (Clovis Oncology)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?